13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...7, 8, 9, 10, 11, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-12-23
5:08 pm
Sale
2022-12-21 13G PHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P 229,930
7.400%
-281,988decrease
(-55.08%)
Filing
History
2022-12-21
4:40 pm
Purchase
2022-12-19 13G Third Harmonic Bio, Inc.
THRD
BIOTECHNOLOGY VALUE FUND L P 4,365,933
10.800%
864,119increase
(+24.68%)
Filing
History
2022-12-16
4:45 pm
Purchase
2022-12-06 13G NLS Pharmaceutics AG
NLSP
BIOTECHNOLOGY VALUE FUND L P 171,479
19.990%
171,479increase
(New Position)
Filing
History
2022-12-05
4:45 pm
Purchase
2022-11-23 13G Kura Oncology, Inc.
KURA
BIOTECHNOLOGY VALUE FUND L P 3,547,083
5.300%
2,301,171increase
(+184.70%)
Filing
History
2022-11-10
4:51 pm
Unchanged
2022-11-08 13D Rain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P 3,526,729
14.200%
0
(Unchanged)
Filing
History
2022-11-07
4:50 pm
Purchase
2022-10-27 13G Aravive, Inc.
ARAV
BIOTECHNOLOGY VALUE FUND L P 6,109,058
9.990%
6,109,058increase
(New Position)
Filing
History
2022-09-29
4:28 pm
Purchase
2022-09-19 13G Allakos Inc.
ALLK
BIOTECHNOLOGY VALUE FUND L P 5,006,921
5.900%
5,006,921increase
(New Position)
Filing
History
2022-09-26
4:57 pm
Purchase
2022-09-15 13G Third Harmonic Bio, Inc.
THRD
BIOTECHNOLOGY VALUE FUND L P 3,501,814
9.100%
3,501,814increase
(New Position)
Filing
History
2022-09-26
4:54 pm
Purchase
2022-09-14 13G POINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P 5,590,048
5.400%
2,669,522increase
(+91.41%)
Filing
History
2022-08-26
5:11 pm
Purchase
2022-08-16 13G Vigil Neuroscience, Inc.
VIGL
BIOTECHNOLOGY VALUE FUND L P 2,739,727
7.500%
2,739,727increase
(New Position)
Filing
History
2022-08-23
4:45 pm
Purchase
2022-08-22 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 4,692,604
8.600%
553,846increase
(+13.38%)
Filing
History
2022-08-11
4:48 pm
Purchase
2022-08-09 13D CTI BioPharma Corp.
CTIC
BIOTECHNOLOGY VALUE FUND L P 28,463,021
19.990%
11,339,998increase
(+66.23%)
Filing
History
2022-07-29
4:37 pm
Purchase
2022-07-27 13G CytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P 6,595,801
10.100%
792,101increase
(+13.65%)
Filing
History
2022-07-19
5:13 pm
Sale
2022-07-15 13G ContraFect Corporation
CFRX
BIOTECHNOLOGY VALUE FUND L P 23,091
4.500%
-26,563decrease
(-53.50%)
Filing
History
2022-07-12
4:40 pm
Purchase
2022-07-08 13G ESSA Pharma Inc.
EPIX
BIOTECHNOLOGY VALUE FUND L P 8,748,629
19.900%
4,183,387increase
(+91.64%)
Filing
History
2022-07-11
5:03 pm
Purchase
2022-06-29 13G 89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P 3,898,000
9.990%
3,898,000increase
(New Position)
Filing
History
2022-06-21
4:53 pm
Purchase
2022-06-16 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 4,007,413
12.400%
2,001,551increase
(+99.79%)
Filing
History
2022-06-16
5:24 pm
Purchase
2022-06-06 13G Centessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P 6,894,345
7.300%
6,894,345increase
(New Position)
Filing
History
2022-06-06
5:25 pm
Purchase
2022-06-02 13G Repare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P 8,141,988
19.400%
3,283,227increase
(+67.57%)
Filing
History
2022-06-01
5:00 pm
Purchase
2022-05-27 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 4,138,758
8.000%
552,100increase
(+15.39%)
Filing
History
Goto Prev, 0, 1, ...7, 8, 9, 10, 11, ...17, 18, Next